ALGSbenzinga

Preview: Aligos Therapeutics's Earnings

Summary

Aligos Therapeutics (NASDAQ:ALGS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Aligos Therapeutics will report an earnings per share (EPS) of $-0.73.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 3, 2022 by benzinga